article thumbnail

Biased research, aggressive sales, harmful drugs

The Health Policy Exchange

In this month's Georgetown University Health Policy seminar, we discussed two examples, anemia drugs and the diabetes drug rosiglitazone (Avandia) , which were prominently featured in recent articles by Peter Whoriskey in The Washington Post. The size of average doses would more than triple.

article thumbnail

Bisphosphonates for Osteoporosis: Podcast with James Deardorff and Sei Lee

GeriPal

James: Yeah, I mean, first of all, I think anything in medicine is not going to be like a slam dunk type thing, except when we’re dealing with like insulin and type one diabetes it’s pretty obvious. It’s like 2007 or something. It’s also important for us to think about when is it going to be helpful.

Clinic 67